Key Insights

Highlights

Success Rate

100% trial completion (above average)

Published Results

14 trials with published results (48%)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 17/100

Termination Rate

0.0%

0 terminated out of 29 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

38%

11 trials in Phase 3/4

Results Transparency

54%

14 of 26 completed with results

Key Signals

14 with results100% success

Data Visualizations

Phase Distribution

29Total
Not Applicable (7)
P 1 (5)
P 2 (6)
P 3 (9)
P 4 (2)

Trial Status

Completed26
Unknown2
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 26 completed trials

Clinical Trials (29)

Showing 20 of 20 trials
NCT07191457Not ApplicableRecruitingPrimary

Safety and Efficacy of Head-lice Treatments Elimax Green Lotion and Walgreens Lice Killing Shampoo

NCT05565820Phase 4Completed

A Study to Evaluate the Efficacy and Safety of a Leave-in Spray in Subjects With Head Lice Infestation

NCT06333054Not ApplicableCompletedPrimary

Safety and Efficacy of a Head Lice Shampoo

NCT02974088Phase 2Completed

Neem Lotion With Combing for Lice

NCT05378477Not ApplicableUnknownPrimary

A Clinical Trial to Evaluate Efficacy and Safety of a New Suffocating Head Lice Product.

NCT03617926Not ApplicableCompletedPrimary

A Clinical Trial to Evaluate Efficacy and Safety of a Water-soluble Head Lice Product.

NCT00528021Phase 2Completed

A Study Evaluating the Safety and Efficacy of BGC20-0582 Lice Treatment Gel for Head Lice Infestation

NCT05379114Not ApplicableUnknownPrimary

Comparative Study for the Evaluation of a New Medical Device on the Treatment of Head Lice Infestation

NCT02061813Phase 1CompletedPrimary

Dermal Safety Study to Evaluate Potential Irritation of Abametapir Lotion

NCT02624843Phase 3CompletedPrimary

Bioequivalence Study for Benzyl Alcohol Lotion 5%.

NCT03337490Phase 3CompletedPrimary

A Clinical Endpoint Bioequivalence Study to Assess Efficacy and Safety of Ivermectin 0.5% Lotion in the Treatment of Head Lice

NCT02062073Phase 1CompletedPrimary

Dermal Safety Study to Evaluate the Sensitizing Potential of Abametapir Lotion

NCT03301649Phase 3CompletedPrimary

Clinical Endpoint Study of Ivermectin 0.5% Lotion

NCT03236168Phase 3Completed

Impact of Community Scabies Treatment on Head Lice Prevalence in the Solomon Islands

NCT01803581Not ApplicableCompletedPrimary

A Study to Evaluate the Safety and Efficacy of Product X92001327 vs RID Shampoo in Subjects With Head Lice

NCT02213055Phase 2CompletedPrimary

Pediatric Head Lice Study Product Comparison

NCT00858481Phase 2Completed

A Pilot Dose Ranging Study of Spinosad Creme Rinse

NCT00988533Phase 1CompletedPrimary

A Pharmacokinetics (PK) Study in Lice Infested Children 6 Months to 3 Years of Age

NCT01068158Phase 3CompletedPrimary

A Study Comparing the Safety and Efficacy of 0.5% Ivermectin Cream to Placebo in Lice Infested Subjects

NCT01066585Phase 3CompletedPrimary

A Safety and Efficacy Study Comparing 0.5% Ivermectin Cream to a Vehicle Control in Subjects With Head Lice Infestation

Scroll to load more

Research Network

Activity Timeline